Effectiveness and safety of baricitinib in patients with severe alopecia areata: a 36-week multicenter real-world experience

Effectiveness and safety of baricitinib in patients with severe alopecia areata: a 36-week multicenter real-world experience

Bibliographic Details
Main Authors:	Luigi Gargiulo, Luciano Ibba, Carlo A. Vignoli, Silvia M. Ferrucci, Santo R. Mercuri, Piergiorgio Malagoli, Angelo V. Marzano, Mauro Barbareschi, Vittoria G. Bianchi, Mario Valenti, Antonio Costanzo, Alessandra Narcisi
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2023-12-01
Series:	Journal of Dermatological Treatment
Online Access:	http://dx.doi.org/10.1080/09546634.2023.2268764

Similar Items

Baricitinib for alopecia areata
by: Hamza Imran, et al.
Published: (2023-04-01)

Alopecia areata treatment with baricitinib: different relapse phenotypes
by: Federica Dall’Oglio, et al.
Published: (2024-12-01)

Atopic Dermatitis and Multilocular Alopecia Areata Simultaneously Treated With Baricitinib
by: M. Pestana, et al.
Published: (2024-02-01)

Efficacy and safety of baricitinib in patients with alopecia areata: evidence to date
by: Sofia Faria, et al.
Published: (2023-09-01)

Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib
by: Ali Jabbari, et al.
Published: (2015-04-01)

Exploring the efficacy of baricitinib in treating alopecia areata after failed Janus kinase inhibitor therapy
by: Olivia Katamanin, BS, et al.
Published: (2024-01-01)

Complete response of extensive alopecia areata refractory to baricitinib after five months of treatment with upadacitinib
by: Francisco Javier De la Torre-Gomar, et al.
Published: (2024-12-01)

Baricitinib Therapy for Moderate to Severe Alopecia Areata: A Retrospective Review of 95 Japanese Patients
by: Takafumi Numata, et al.
Published: (2024-01-01)

[Artículo traducido] Dermatitis atópica y alopecia areata multilocular tratadas simultáneamente con baricitinib
by: M. Pestana, et al.
Published: (2024-02-01)

Clinical Benefits of Baricitinib Therapy According to Scalp Hair Regrowth in Patients with Severe Alopecia Areata
by: Maryanne M. Senna, et al.
Published: (2023-11-01)

Real-life effectiveness and safety of dupilumab in adolescents with atopic dermatitis: a 52-week single-center retrospective study
by: Luigi Gargiulo, et al.
Published: (2023-04-01)

Case report: Dupilumab therapy for alopecia areata in a 4-year-old patient resistant to baricitinib
by: Lu Cai, et al.
Published: (2023-10-01)

Tralokinumab rapidly improves subjective symptoms and quality of life in patients with moderate-to-severe atopic dermatitis: a real-life 16-week experience
by: Luigi Gargiulo, et al.
Published: (2023-12-01)

Real-Life Effectiveness and Tolerance of Baricitinib for the Treatment of Severe Alopecia Areata with 1-Year Follow-Up Data
by: Axel De Greef, et al.
Published: (2023-09-01)

Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
by: Kabir Sardana, et al.
Published: (2023-01-01)

A severe psoriasis flare after COVID-19 treated with risankizumab: complete skin clearance after 16 weeks
by: Luciano Ibba, et al.
Published: (2023-06-01)

Alopecia areata incognita
by: Luciana Molina, et al.
Published: (2011-01-01)

Alopecia areata universal
by: Edna Gabriela Delgado Quiñones, et al.

Immunopathogenesis of alopecia areata
by: Jadesola (Jadé) Temitope Olayinka, et al.
Published: (2021-01-01)

Penatalaksanaan Alopecia Areata (Treatment of Allopecia Areata)
by: Agatha Anindhita Ayu Ardhaninggar, et al.
Published: (2018-05-01)

Alopecia areata: revisão e atualização Alopecia areata: a revision and update
by: Evandro A. Rivitti
Published: (2005-02-01)

Adalimumab-induced paradoxical pustular psoriasis and alopecia successfully treated with ixekizumab in a patient affected by hidradenitis suppurativa
by: Carlo Alberto Vignoli, et al.
Published: (2023-12-01)

Perinevoid alopecia: an unusual presentation of alopecia areata
by: Jose Leonardo Rodrigues Machado, et al.
Published: (2022-07-01)

Oxidative stress and alopecia areata
by: Yi-qian Ma, et al.
Published: (2023-06-01)

Gut microbiota in alopecia areata
by: Karolina Brzychcy, et al.
Published: (2022-12-01)

Alopecia Areata With Folliculitis Decalvans
by: Kumar Kailash, et al.
Published: (1997-01-01)

Alopecia areata difficult case
by: Anca Chiriac, et al.
Published: (2012-12-01)

Alopecia Areata and Suicide Ideation
by: Chiriac Anca, et al.
Published: (2017-03-01)

Alopecia areata, morphea and psoriasis
by: Koray Durmaz, et al.
Published: (2020-09-01)

Alopecia areata: medical treatments
by: Zonunsanga
Published: (2015-01-01)

Alopecia areata: Update on management
by: Julie S Kranseler, et al.
Published: (2017-01-01)

Alopecia areata: Treatment options
by: E. Kasumagić-Halilović, et al.
Published: (2006-02-01)

Utility of dermoscopy in alopecia areata
by: Mandar Mane, et al.
Published: (2011-01-01)

CORTICOSTEROID AS TREATMENT OF ALOPECIA AREATA
by: Ni Putu Junika Putri, et al.
Published: (2013-04-01)

Design and Characterization of Baricitinib Incorporated PLA 3D Printed Pills by Fused Deposition Modeling: An Oral Pill for Treating Alopecia Areata
by: Mohammed Muqtader Ahmed, et al.
Published: (2023-04-01)

Dupilumab for the treatment of atopic dermatitis of the elderly: a real-life 52-week experience
by: Luigi Gargiulo, et al.
Published: (2023-12-01)

Practical Use of Upadacitinib in Patients with Severe Atopic Dermatitis in a Real-World Setting: A Systematic Review
by: Ibba L, et al.
Published: (2024-03-01)

Efficacy of Baricitinib in Patients with Various Degrees of Alopecia Areata Severity: Post-Hoc Analysis from BRAVE AA1 and BRAVE AA2
by: Susan Taylor, et al.
Published: (2023-09-01)

Evaluation of the quality of life in patients with alopecia areata and androgenetic alopecia
by: I. N. Kondrakhina, et al.
Published: (2017-08-01)

Comparison of quality of life in patients with androgenetic alopecia and alopecia areata
by: Muzeyyen Gonul, et al.
Published: (2018-10-01)